← Leaderboards
Grant R. Wilkinson
Vanderbilt University
$1,933,364
Attributed
$1,933,364
Total exposure
14
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–06$2M$1.5M$1M$500K$0
'05
'06
Funding mix
By agency
NIH$9,106,218 · 15
By mechanism
P01$7,581,324 · 3
R01$805,674 · 1
M01$719,220 · 11
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- F Peter Guengerich$48,178,939
- Steven D Hollon$9,788,867
- Dana Borden Lacy$9,960,545
- David W. Piston$26,670,947
- Alastair J. J. Wood$1,021,454
Others in their field
Top investigators on “Cytochrome P450”
- Eric F Johnson · Scripps Research Institute$21,555,814
- Irina A Pikuleva · University Of Texas Medical Br Galveston$15,661,223
- Maria Almira Correia · University Of California San Francisco$15,613,829
- Bhagavatula Moorthy · Baylor College Of Medicine$14,960,433
- Kafait U Malik · University Of Tennessee Health Sci Ctr$14,014,312
- Michal Laniado Schwartzman · New York Medical College$13,763,631
Research focus
Cytochrome P450Clinical ResearchHuman SubjectEnzyme ActivityIsozymesDrug MetabolismOral AdministrationMidazolamChemopreventionGenetic PolymorphismDrug InteractionsOltiprazClearance RatePharmacokineticsRacial /Ethnic DifferencePharmacogeneticsMuscle RelaxantsFamily GeneticsEnzyme Induction /RepressionEnzyme InhibitorsGenetic TranscriptionAllelesHydroxylationDebrisoquin
Grant awards (44)
CYP2B6 POLYMORPHISMS: NEVIRAPINE/EFAVIRENZ METABOLISM$321,306
M01 · FY2006 · RR · contact PI
INHERITABILITY OF CYP3A ACTIVITY$26,427
M01 · FY2006 · RR · contact PI
DETERMINANTS OF INDIVIDUAL RESPONSIVENESS TO DRUGS$1,231,603
P01 · FY2005 · GM
CYP2B6 POLYMORPHISMS: NEVIRAPINE/EFAVIRENZ METABOLISM$299,129
M01 · FY2005 · RR
BENZODIAZEPINE METABOLISM AS AN IN VIVO PROBE OF CYP3A ACTIVITY$1,382
M01 · FY2005 · RR
DETERMINANTS OF INDIVIDUAL RESPONSIVENESS TO DRUGS$1,202,331
P01 · FY2004 · GM
Benzodiazepine Metabolism as an In vivo Probe of CYP3A Activity$67,674
M01 · FY2004 · RR
Effect of CYP3A4 Polymorphisms on Basal and Induced Enzyme Activity$1,651
M01 · FY2004 · RR
Effect of Oltipraz on Cytochrome P450 Activity.$1,651
M01 · FY2004 · RR
DETERMINANTS OF INDIVIDUAL RESPONSIVENESS TO DRUGS$1,267,025
P01 · FY2003 · GM
DETERMINANTS OF INDIVIDUAL RESPONSIVENESS TO DRUGS$1,249,472
P01 · FY2002 · GM
CHEMOPREVENTIVE AGENTS AND HUMAN CYTOCHROME P450 IN VIVO$263,244
R01 · FY2002 · CA
EFFECT OF OLTIPRAZ ON CYTOCHROME P450 ACTIVITY$0
M01 · FY2002 · RR
MIDAZOLAM PROBE FOR CYP4503A4 ACTIVITY$0
M01 · FY2002 · RR
CHLORZOXAZONE 6-HYDROXYLATION IN VIVO PROBE OF CP450$0
M01 · FY2002 · RR
CYP3A4 POLYMORPHISMS ON BASAL AND INDUCED ENZYME ACTIVITY$0
M01 · FY2002 · RR
Genetic and Other Determinants of In Vivo CYP3A Activity$0
P01 · FY2002 · GM
EFFECT OF PIPERINE ON CYTOCHROME P450 ACTIVITY$0
M01 · FY2002 · RR
DETERMINANTS OF INDIVIDUAL RESPONSIVENESS TO DRUGS$1,125,019
P01 · FY2001 · GM
CHEMOPREVENTIVE AGENTS AND HUMAN CYTOCHROME P450 IN VIVO$274,202
R01 · FY2001 · CA
INTERRACIAL DIFFERENCES IN CYTOCHROME P450 MEDIATED METABOLISM$140,822
P01 · FY2001 · GM
CYP3A4 POLYMORPHISMS ON BASAL AND INDUCED ENZYME ACTIVITY$0
M01 · FY2001 · RR
CHLORZOXAZONE 6-HYDROXYLATION IN VIVO PROBE OF CP450$0
M01 · FY2001 · RR
CHLORZOXAZONE 6-HYDROXYLATION IN VIVO PROBE OF CP450$0
M01 · FY2001 · RR
CHLORZOXAZONE 6-HYDROXYLATION IN VIVO PROBE OF CP450$0
M01 · FY2001 · RR
MIDAZOLAM PROBE FOR CYP4503A4 ACTIVITY$0
M01 · FY2001 · RR
MIDAZOLAM PROBE FOR CYP4503A4 ACTIVITY$0
M01 · FY2001 · RR
MIDAZOLAM PROBE FOR CYP4503A4 ACTIVITY$0
M01 · FY2001 · RR
EFFECT OF OLTIPRAZ ON CYTOCHROME P450 ACTIVITY$0
M01 · FY2001 · RR
EFFECT OF OLTIPRAZ ON CYTOCHROME P450 ACTIVITY$0
M01 · FY2001 · RR
EFFECT OF OLTIPRAZ ON CYTOCHROME P450 ACTIVITY$0
M01 · FY2001 · RR
EFFECT OF PIPERINE ON CYTOCHROME P450 ACTIVITY$0
M01 · FY2001 · RR
EFFECT OF PIPERINE ON CYTOCHROME P450 ACTIVITY$0
M01 · FY2001 · RR
EFFECT OF PIPERINE ON CYTOCHROME P450 ACTIVITY$0
M01 · FY2001 · RR
CYP3A4 POLYMORPHISMS ON BASAL AND INDUCED ENZYME ACTIVITY$0
M01 · FY2001 · RR
CYP3A4 POLYMORPHISMS ON BASAL AND INDUCED ENZYME ACTIVITY$0
M01 · FY2001 · RR
DETERMINANTS OF INDIVIDUAL RESPONSIVENESS TO DRUGS$1,097,404
P01 · FY2000 · GM
CHEMOPREVENTIVE AGENTS AND HUMAN CYTOCHROME P450 IN VIVO$268,228
R01 · FY2000 · CA
INTERRACIAL DIFFERENCES IN CYTOCHROME P450 MEDIATED METABOLISM$267,648
P01 · FY2000 · GM
CYP3A4 POLYMORPHISMS ON BASAL AND INDUCED ENZYME ACTIVITY$0
M01 · FY2000 · RR
EFFECT OF OLTIPRAZ ON CYTOCHROME P450 ACTIVITY$0
M01 · FY2000 · RR
EFFECT OF PIPERINE ON CYTOCHROME P450 ACTIVITY$0
M01 · FY2000 · RR
MIDAZOLAM PROBE FOR CYP4503A4 ACTIVITY$0
M01 · FY2000 · RR
CHLORZOXAZONE 6-HYDROXYLATION IN VIVO PROBE OF CP450$0
M01 · FY2000 · RR